J

Active Director Director DIN 10202285
DIN 10202285 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Jyoti

Data last updated:

Jyoti is a Director at Kveepreksh Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Kveepreksh Pharmaceuticals Private Limited reported revenue of ₹1.4 Lakh (FY 2025).

DIN 10202285
Primary Designation Director
Industry Pharma
First Appointment 13 Jun 2023
Oldest Company Age 3 yrs
Largest company Kveepreksh Pharmaceuticals Private Limited · ₹1.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jun 20232023₹1.4 Lakh (FY 2025)Active

Board colleagues of Jyoti

NameDINCompanyDesignation
Kishan Sharma08845251Kveepreksh Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kveepreksh Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jyoti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti

Jyoti currently holds 1 directorship: Kveepreksh Pharmaceuticals Private Limited (Director, since 13 Jun 2023, revenue ₹1.4 Lakh (FY 2025)).

Jyoti was first appointed on 13 Jun 2023 as Director at Kveepreksh Pharmaceuticals Private Limited.

The current boards of Jyoti's companies include Kishan Sharma (Kveepreksh Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available